Beam Therapeutics Inc.’s BEAM share price has dipped by 11.15%, which has investors questioning if this is right time to buy.

Learn more about whether Alvotech or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which ...

RNA-based therapeutics are gaining traction due to advancements in delivery technologies, despite historical challenges with ...

Rutgers faculty elected to the newest class of fellows of the American Association for the Advancement of Science (AAAS) are ...

Orna Therapeutics, a biotechnology company dedicated to engineering immune cells in vivo to treat oncology and autoimmune diseases, today announced the appointment of Joseph Bolen, Ph.D., as Chief ...

Vertex Pharmaceuticals Incorporated today announced several updates on the Company's type 1 diabetes (T1D) portfolio. VX-264 Update Vertex has completed enrollment and dosing in Parts A and B of the ...

Boston Children's Hospital is the fourth largest recipient of NIH grants in the country. Last year, it received $218 million ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at ...

IF PAULA MENDES achieves her goals, her nanotechnology innovations will soon allow doctors to diagnose cancer with greater ...

Avianah Drakeford was born with sickle cell disease, a genetic disorder that negatively affects how blood moves around the ...

Are you a sickle cell warrior or do you know someone with sickle cell disease? At Social Security, we’re committed to supporting sickle cell warriors and the people who care for them.

Avianah Drakeford was born with sickle cell disease, a genetic disorder that negatively affects how blood moves around the body. It's not life-threatening, but it is life-altering. "The last thing ...